Literature DB >> 32615118

Cancer registration in China and its role in cancer prevention and control.

Wenqiang Wei1, Hongmei Zeng1, Rongshou Zheng1, Siwei Zhang1, Lan An1, Ru Chen1, Shaoming Wang1, Kexin Sun1, Tomohiro Matsuda2, Freddie Bray3, Jie He4.   

Abstract

Cancer has become a leading cause of death in China, with an increasing burden of cancer incidence and mortality observed over the past half century. Population-based cancer registries have been operating in China for about 60 years, and, in 2018, their role has expanded to include the formulation and evaluation of national cancer control programmes and the care of patients with cancer. The purpose of this Review is to provide an overview of the key milestones in the development of cancer registration in China, the current status of registry coverage and quality, and a description of the changing cancer profile in China from 1973 to 2015. This Review is a comprehensive and updated review on the development of population-based cancer registries in China over a 60-year time span. We highlight some aspects of cancer control plans that illustrate how cancer registration data have become central to the identification of health priorities for China and provide a means to track progress in cancer control for the country.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32615118     DOI: 10.1016/S1470-2045(20)30073-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  73 in total

1.  Changing incidence and projections of thyroid cancer in mainland China, 1983-2032: evidence from Cancer Incidence in Five Continents.

Authors:  Mandi Li; Jiao Pei; Minghan Xu; Ting Shu; Chengjie Qin; Meijing Hu; Yawei Zhang; Min Jiang; Cairong Zhu
Journal:  Cancer Causes Control       Date:  2021-06-21       Impact factor: 2.506

2.  Down-Regulation of Hypoxia-Inducible Factor-1α and Downstream Glucose Transporter Protein-1 Gene by β-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor.

Authors:  Wenbo Wu; Zhonghui Hu; Qingtao Zhao; Xiaopeng Zhang; Hua Zhang; Huien Wang; Wenfei Xue; Lei Yu; Guochen Duan
Journal:  Onco Targets Ther       Date:  2020-11-13       Impact factor: 4.147

3.  Patient participation in treatment decision-making of prostate cancer: a qualitative study.

Authors:  Shucheng Pan; Jinjiao Mao; Lijuan Wang; Yun Dai; Wei Wang
Journal:  Support Care Cancer       Date:  2022-01-27       Impact factor: 3.603

4.  Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.

Authors:  Yi Liao; Dingxiu He; Fuqiang Wen
Journal:  Immunogenetics       Date:  2021-07-24       Impact factor: 2.846

5.  Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.

Authors:  Anqi Cheng; Xiong Guo; Xinglong Dai; Ziwei Wang
Journal:  FEBS Open Bio       Date:  2021-05-24       Impact factor: 2.693

6.  Predictions of mortality related to four major cancers in China, 2020 to 2030.

Authors:  Ning Li; Peng Wu; Yubing Shen; Cuihong Yang; Luwen Zhang; Yali Chen; Zixing Wang; Jingmei Jiang
Journal:  Cancer Commun (Lond)       Date:  2021-03-03

7.  YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways.

Authors:  Xiao Li; Caixia Wang; Shuang Wang; Yuexin Hu; Shan Jin; Ouxuan Liu; Rui Gou; Xin Nie; Juanjuan Liu; Bei Lin
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

8.  Untargeted metabolomics and transcriptomics identified glutathione metabolism disturbance and PCS and TMAO as potential biomarkers for ER stress in lung.

Authors:  Zijing Wang; Peng Ma; Yisa Wang; Biyu Hou; Can Zhou; He Tian; Bowen Li; Guanghou Shui; Xiuying Yang; Guifen Qiang; Chengqian Yin; Guanhua Du
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

9.  Qiyusanlong Formula Induces Autophagy in Non-Small-Cell Lung Cancer Cells and Xenografts through the mTOR Signaling Pathway.

Authors:  Yating Gao; Xinheng Wang; Qinjun Yang; Xiaole Wang; Xingxing Zhang; Jiabing Tong; Cheng Yang; Di Wu; Zegeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-22       Impact factor: 2.629

10.  Patterns and trends of cancer incidence in children and adolescents in China, 2011-2015: A population-based cancer registry study.

Authors:  Kexin Sun; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Shaoming Wang; Ru Chen; Wenqiang Wei; Jie He
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.